Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

A Parallel Reaction Monitoring Mass Spectrometric Method for Analysis of Potential CSF Biomarkers for Alzheimer's Disease

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review


  1. Candidate biomarker verification: Critical examination of a serum protein pattern for human colorectal cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Proteomic biomarkers for overall and progression-free survival in ovarian cancer patients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Comparison of proteomic biomarker panels in urine and serum for ovarian cancer diagnosis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Imaging of the Serotonin System: Radiotracers and Applications in Memory Disorders

    Publikation: Bidrag til bog/antologi/rapportBidrag til bog/antologiUndervisning

  2. Undersøgelse af spinalvæske ved udredning for kognitiv svækkelse og demens

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

SCOPE: The aim of this study was to develop and evaluate a parallel reaction monitoring mass spectrometry (PRM-MS) assay consisting of a panel of potential protein biomarkers in cerebrospinal fluid (CSF).

EXPERIMENTAL DESIGN: Thirteen proteins were selected based on their association with neurodegenerative diseases and involvement in synaptic function, secretory vesicle function, or innate immune system. CSF samples were digested and two to three peptides per protein were quantified using stable isotope-labeled peptide standards.

RESULTS: Coefficients of variation were generally below 15%. Clinical evaluation was performed on a cohort of 10 patients with Alzheimer's disease (AD) and 15 healthy subjects. Investigated proteins of the granin family exhibited the largest difference between the patient groups. Secretogranin-2 (p<0.005) and neurosecretory protein VGF (p<0.001) concentrations were lowered in AD. For chromogranin A, two of three peptides had significantly lowered AD concentrations (p<0.01). The concentrations of the synaptic proteins neurexin-1 and neuronal pentraxin-1, as well as neurofascin were also significantly lowered in AD (p<0.05). The other investigated proteins, β2-microglobulin, cystatin C, amyloid precursor protein, lysozyme C, neurexin-2, neurexin-3, and neurocan core protein, were not significantly altered.

CONCLUSION AND CLINICAL RELEVANCE: PRM-MS of protein panels is a valuable tool to evaluate biomarker candidates for neurodegenerative disorders.

TidsskriftProteomics - Clinical Applications
Udgave nummer1
Sider (fra-til)e
StatusUdgivet - 2018

ID: 52182730